| 常用名 | ZGN-1061 | CAS号 | 2082752-83-6 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: ZGN-1061 (Aclimostat) is a novel potent, selective Methionine aminopeptidase 2 (MetAP2) inhibitor being investigated for treatment of diabetes and obesity; reduces body weight in diet-induced obese (DIO) insulin-resistant mice, also produced improvements in metabolic parameters, including plasma glucose and insulin, and, in HepG2 cells, initiated gene changes similar to beloranib; does not increase coagulation markers in dogs and ZGN-1061 had a greatly improved safety profile in rats relative to beloranib. Diabetes Phase 2 Clinical 物理化学性质: CAS号:2082752-83-6 常用中文名:ZGN-1061 常用英文名:ZGN-1061 分子式:C26H42N2O6 分子量:478.63 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |